Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, Francesca Rocchio, Valentina Tini, Barbara Bigerna, Paolo Sportoletti, Simona Caruso, Andrea Marra, Giulio Spinozzi, Sharon Shacham, Yosef Landesman, Concetta Quintarelli, Franco Locatelli, Maria Paola Martelli, Brunangelo Falini, Lorenzo Brunetti

Journal title: bioRxiv

Journal publisher: Cold Spring Harbor Laboratory

Published year: 2022

DOI identifier: 10.1101/2021.12.11.472216